Key Insights

Highlights

Success Rate

83% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

2.0%

1 terminated out of 51 trials

Success Rate

83.3%

-3.2% vs benchmark

Late-Stage Pipeline

8%

4 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed with results

Key Signals

83% success

Data Visualizations

Phase Distribution

38Total
Not Applicable (24)
Early P 1 (1)
P 1 (2)
P 2 (7)
P 3 (4)

Trial Status

Recruiting22
Not Yet Recruiting15
Enrolling By Invitation6
Completed5
Active Not Recruiting2
Terminated1

Trial Success Rate

83.3%

Benchmark: 86.5%

Based on 5 completed trials

Clinical Trials (51)

Showing 20 of 20 trials
NCT06917313Phase 2RecruitingPrimary

FLASH-Breast: Evaluating the Efficacy of Fezolinetant in Reducing Vasomotor Symptoms in Women With Breast Cancer on Endocrine Therapy

NCT07387445Not ApplicableRecruitingPrimary

Feasibility and Acceptibility of a Multi-site Trial of Time Restircted Eating During Chemotheraply for Breast Cancer.

NCT06865755Not ApplicableNot Yet Recruiting

Collaborative Research: Multiscale Modeling and Intervention for Improving Long-Term Medication

NCT06807502Not ApplicableRecruiting

Evaluation of Circulating Tumor Cells (CTC) Relevance in Breast Cancer Follow-up Using the ScreenCell Device

NCT07398118Not ApplicableNot Yet Recruiting

CRYO-1: Cryoablation in Elderly Patients With Early-Stage Breast Cancer.

NCT06834204Not ApplicableNot Yet Recruiting

Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors

NCT06723990RecruitingPrimary

Evaluation of HER2DX Assay on Treatment Decisions in Patients With Early Stage HER2+ Breast Cancer: the HER2BREASTDX

NCT07372261Enrolling By InvitationPrimary

Validation of a Prognostic Method for Assessing the Risk of Distant Metastasis in Early-stage Breast Cancer

NCT06791018Not ApplicableActive Not Recruiting

Cancer Exercise: Evaluation of a Mobile App in Breast Cancer Survivors

NCT07373782Phase 2RecruitingPrimary

Continuous Positive Airway Pressure (CPAP) Assisted Radiotherapy in Breast Cancer

NCT06970912Phase 2Recruiting

ctDNA-Guided De-Escalation of Adjuvant Chemotherapy With Dalpiciclib in HR-Positive/HER2-Negative Breast Cancer

NCT07107594Not ApplicableRecruitingPrimary

Multimodal Prehabilitation Program That Combines Physical Exercise, Psychological Intervention and Nutritional Support to Improve the Response to Neoadjuvant Chemoterhapy in Early Breast Cancer Patients

NCT07331506Recruiting

Validation of the Oncoliq Test for the Early Detection of Breast Cancer.

NCT07317778Phase 2Not Yet RecruitingPrimary

Chemotherapy With or Without Adebrelimab and T-DXh as Neoadjuvant Therapy for HR+/HER2 Low Early Stage Breast Cancer

NCT07311317Not Yet RecruitingPrimary

Cellular-Level Fluorescence Imaging for Intraoperative Margin Assessment in Breast Cancer

NCT06924788Not ApplicableEnrolling By InvitationPrimary

Video-Conferenced Stress Management and Relaxation Training (VSMART) For Alabama Breast Cancer Survivors

NCT07273357Not Yet Recruiting

Aspects of Adjuvant CDK4/6 Inhibitors in Older Breast Cancer Patients - Focusing on Geriatric Screening

NCT07269691Phase 3Not Yet RecruitingPrimary

RaSOLVE: 125I Radioactive Seed Marking Effects on Pathological Complete Response Rate and Prognosis Post-Neoadjuvant Therapy in Early/Advanced Breast Cancer

NCT06781996Phase 3Recruiting

A Study to Determine the Efficacy of a Digital Self-management Support Tool to Improve the Quality of Life During Adjuvant HOrmonal Therapy for Patients With Early Breast Cancer

NCT06885671Not ApplicableNot Yet RecruitingPrimary

Single vs Hypofractionated Irradiation For Timely Access to Partial Breast Radiotherapy

Scroll to load more

Research Network

Activity Timeline